Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Chubb
McKinsey
Chinese Patent Office
Cipla
Teva

Generated: June 27, 2019

DrugPatentWatch Database Preview

Litigation Details for Connetics Corporation v. Pentech Pharmaceuticals Inc (N.D. Ill. 2008)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Connetics Corporation v. Pentech Pharmaceuticals Inc (N.D. Ill. 2008)

Docket ➤ Sign Up Date Filed 2008-04-18
Court District Court, N.D. Illinois Date Terminated 2009-08-14
Cause 35:271 Patent Infringement Assigned To Harry Daniel Leinenweber
Jury Demand Defendant Referred To
Parties CONNETICS CORPORATION; PENTECH PHARMACEUTICALS INC; STIEFEL RESEARCH AUSTRALIA PTY. LTD
Patents 6,126,920
Attorneys Andrew M. Berdon; Brian J Sodikoff; Bruce Chasan; Craig M Kuchii; Jolie Apicella; Joseph Milowic , III; Maria Granovsky; Mark D. Baker; Mona Gupta; Peter S. Roeser; Robert B Wilson; Robert B. Breisblatt; Robert S Silver; Robert W. Stevenson; Sharyn Marie Castle; Stephen P. Benson; Thomas Joseph Dammrich , II; William C. Youngblood; William J Castillo
Firms Caesar, Revise, Bernstein, Cohen & Pokotilow, Ltd.; Caesar, Rivise, Bernstein, Cohen & Pokotilow, LTD; Caesar, Rivise, Bernstein, Cohen, & Pokotilow, Ltd.; Katten Muchin Rosenman LLP; Quinn Emanuel Urquhart Oliver & Hedges LLP; Roeser Bucheit & Graham LLC; Shook, Hardy & Bacon LLP (Chicago)
Link to Docket External link to docket
Small Molecule Drugs cited in Connetics Corporation v. Pentech Pharmaceuticals Inc
The small molecule drugs covered by the patent cited in this case are ➤ Sign Up and ➤ Sign Up .

Details for Connetics Corporation v. Pentech Pharmaceuticals Inc (N.D. Ill. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-04-18 1 complaint U.S. PATENT NO. 6,126,920 8. On October 3, 2000, United States Patent No. 6,126,920 (“the…Certification of Non-Infringement of United States Patent No. 6,126,920” in which Pentech informed Connetics Corporation… 6,126,9206,126,920 1 … 6,126,920 3 External link to document
2008-05-06 10 answer to complaint . S. PATENT NO. 6,126,920 8. On October 3, 2000, United States Patent No. 6,126,920 ("…that they are the owner of U.S. Patent No. 6,126,920 (“the ‘920 patent”), including the right to sue and…Certification of Non-Infringement of United States Patent Nos. 6,126,920” in which Pentech informed Connetics Corporation…all right, title and interest in the U.S. Patent No. 6,126,920, including the right to sue and collect…lawsuit is a civil action for patent infringement arising under the patent laws of United States, 35 U. External link to document
2008-05-22 17 claim that they are the owner of U.S. Patent No. 6,126,920 (“the ‘920 patent”), including the right to sue and…all right, title and interest in the U.S. Patent No. 6,126,920, including the right to sue and collect … of the ‘920 patent and allege that Counterclaim-Plaintiff has infringed the ‘920 patent. RESPONSE… owner of the ‘920 patent, and that Pentech has and will infringe the ‘920 patent. 12. As …Australia is the assignee and owner of the ‘920 patent. 8. On information and belief, Stiefel External link to document
2008-04-18 6 other U.S. Patent United States Patent No. 6,126,920, entitled “METHOD OF No. 6,126,920 TREATING…complaint asserting claims of patent infringement including the parties and the patents below. This notice serves… NOTICE OF CLAIMS involving patents pursuant to 35 U.S.C. 290 by Connetics Corporation, Stiefel … ) NOTICE OF CLAIMS INVOLVING PATENTS PURSUANT TO 35 U.S.C. § 290 PLEASE TAKE…2008 14 August 2009 1:08-cv-02230 830 Patent Defendant District Court, N.D External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Medtronic
Chinese Patent Office
Argus Health
US Department of Justice
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.